Go to interview with Peter M Ravdin, MD, PhD
Go to interview with Lillie Shockney, RN, BS, MAS
Go to interview with Ms G
Go to interview with Ms K
 
 
 
To listen to individual tracks now, click on the track you wish to listen to.
To download tracks, right-click on the one you wish to download.
 
     
Sparano, MD Peter M Ravdin, MD, PhD
Clinical Professor of Medicine
The University of Texas
Health Science Center at San Antonio
San Antonio, Texas

 
  Click here to download the entire interview  
Track 1 Reduction in the use of menopausal hormone replacement therapy as a contributor to
a decline in breast cancer incidence
Track 2 Data from randomized clinical trials evaluating hormone replacement therapy
Track 3 Revision of national guidelines regarding the use of hormone replacement therapy
Track 4 Benefits and risks associated with progesterone in hormone replacement therapy
Track 5 Short-term side effects of cytotoxic chemotherapy
Track 6 Neutropenia and fatigue secondary to chemotherapy Arrow
Track 7 Leukemia and cardiotoxicity risks associated with the use of anthracyclines Arrow
Track 8 Doxorubicin/cyclophosphamide (AC) versus docetaxel/cyclophosphamide (TC) in the adjuvant setting Arrow
Track 9 Side effects of docetaxel Arrow
Track 10 Cardiotoxicity of adjuvant docetaxel/carboplatin/trastuzumab versus AC arrowdocetaxel/ trastuzumab combinations Arrow
Track 11 Risk of congestive heart failure with trastuzumab versus anthracyclines Arrow
Track 12 Role of nonanthracycline-based regimens in the adjuvant setting Arrow
Track 13 Adjuvant aromatase inhibitors versus tamoxifen in postmenopausal patients Arrow
Track 14 Toxicity profiles of tamoxifen versus aromatase inhibitors Arrow
Track 15 Management of arthralgias secondary to aromatase inhibitors Arrow
     
     
Shockneym MD Lillie Shockney, RN, BS, MAS
Administrative Director of Breast Center
Instructor, Faculty — Dept of Surgery
Johns Hopkins University School of Medicine
Johns Hopkins Avon Foundation
Breast Center
Baltimore, Maryland

 
  Click here to download the entire interview  
Track 1 Personal history of two breast cancers
Track 2 Management of tamoxifen-related side effects
Track 3 Understanding the mind-set of a patient with newly diagnosed breast cancer
Track 4 Clinical use of the Oncotype DX™ assay
Track 5 Enrolling patients on the TAILORx trial
Track 6 Patient adherence with oral endocrine therapy
Track 7 Likelihood of adherence to long-term endocrine therapy
Track 8 Helping patients understand and manage arthralgias secondary to aromatase inhibitors
Track 9 Impact of adjuvant trastuzumab on quality of life
Track 10 Providing emotional support for patients with newly diagnosed metastatic disease
Track 11 Dealing with cancer as a survivor and healthcare professional
Track 12 Impact of bevacizumab on progression-free survival and quality of life
Track 13 Potential benefits of nanoparticle albumin-bound (nab) paclitaxel
Track 14 Administration and tolerability of fulvestrant
Track 15 Psychosocial support for patients with metastatic breast cancer
     
  Ms G

 
  Click here to download the entire interview  
Track 1 Patient interview: A 49-year-old physician with ER-negative, PR-negative, HER2-positive,
node-negative breast cancer
Audio
Track 2 Management and prevention of neutropenia secondary to chemotherapy
Track 3 Patient’s experience with treatment-related side effects Audio
Track 4 Cognitive impairment associated with chemotherapy Audio
Track 5 Personal perspective on delayed adjuvant trastuzumab Audio
Track 6 Dealing with teenage daughters when diagnosed with breast cancer Audio
Track 7 Change in personal outlook and life perspective after breast cancer Audio
Track 8 Patient’s advice on coping with cancer

     
  Ms K
 
  Click here to download the entire interview  
Track 1 Patient interview: A 55-year-old woman treated eight years ago for ER-positive, HER2-negative breast cancer with one positive node
Track 2 Patient’s experience with chemotherapy-related side effects
Track 3 Management of hot flashes secondary to endocrine therapy
Track 4 Impact of cancer on a patient’s relationships and outlook on life

 

Home Terms and Conditions of Use of General Disclaimer | Privacy Policy
Copyright © 2007 Research To Practice, All Rights Reserved
Contact us